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Summary Psychosocial factors are thought to influence risk and survival from cancer. We have previously
studied specific behaviours in transgenic male CD-1 MT42 mice, which overexpress the gene encoding human
transforming growth factor a (TGFa) in multiple tissues, and which develop a high incidence of spontaneous
hepatocellular carcinoma. The male TGFa mice spent a lengthened time immobile in the swim test, were
highly aggressive, had increased plasma levels of 17p-estradiol (E2), and reduced natural killer (NK) cell
activity. The female transgenic MT42 TGFa mice do not develop an increased rate of tumours at any site. We
hypothesised that if the alterations in male TGFa mice are associated with their development of hepatocellular
carcinomas, female TGFa should not show these alterations. The data in the present study indicate that female
TGFa mice display shortened immobility in the swim test, suggesting an improved ability to cope with stress,
and appear less aggressive in the resident-intruder test than non-transgenic female CD-1 mice. The female
TGFa mice also exhibit a 3-fold increase in the plasma levels of E2, and a 3-fold increase in NK cell
activity.
These findings suggest that the elevated expression of TGFa in the transgenic mice is associated with
gender-specific behavioural alterations, and the development of spontaneous hepatocellular tumours in the
males. Furthermore, TGFa alters hormonal and immune parameters similarly in both sexes. It remains to be
determined whether the developmAent of hepatocarcinoma in the male TGFa animals is associated with an
impaired ability to cope with stress and elevated aggressive tendencies and/or whether manipulations leading
to an impaired ability to cope with stress will promote tumourigenesis in female TGFa mice.
Transforming growth factor a (TGFa) is a polypeptide which
exhibits approximately 35% sequence homology to epidermal
growth factor (EGF), and interacts with cells through the
EGF receptor. Both TGFx and EGF can act as potent
mitogens in a number of epithelial cell systems (Carpenter &
Cohen, 1979). It has been postulated that TGFa plays an
important role in neoplastic transformation, since it is highly
expressed along with its receptor in many TGFa growth
responsive tumour cells (Bates et al., 1988; Derynck et al.,
1987; Rosenthal et al., 1986; Watanabe et al., 1987). The
results of studies with transgenic CD-1 mice, in which
chronic overexpression of TGFa is directed by the metal-
lothionein (MT) promotor to multiple tissues throughout
their life (Jhappan et al., 1990; Sandgren et al., 1990), have
shown that male mice bearing a TGFa transgene develop a
high incidence of spontaneous hepatocarcinomas at the age
of 10-15 months (Jhappan et al., 1990). Other abnormalities
in these animals (stomach, pancreas, etc.) have emerged as
studies have proceeded.
Human and animal data suggest that an ability to cope
with stress influences vulnerability to develop cancer
(Hilakivi-Clarke et al., 1993b; Holland, 1989; Sklar & Anis-
man, 1981). Perturbations in natural killer (NK) cell activity
(Chuang et al., 1990; Saibara et al., 1989; Shirai et al., 1990)
and steroid hormone levels (d'Arville & Johnson, 1990;
Yager & Shi, 1991) may mediate the effects of psychosocial
factors in cancer. We have utilised transgenic male MT42
TGFax mice in studies assessing those behaviours associated
with tumourigenesis (Hilakivi-Clarke et al., 1992a). When
compared with age matched non-tran sgenic control CD-1
mice, 2-3-month-old male transgenic TGFa mice spent
significantly longer times immobile in Porsolt's swim test,
and in aggressive behaviour (Hilakivi-Clarke et al., 1992a).
The male TGFa mice also exhibited a 25% lower NK cell
activity, and a 4-fold increase in the plasma levels of 17p-
estradiol (E2) than the controls (Hilakivi-Clarke et al., 1992).
The results suggest that the effects of TGFx on hepatocel-
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lular carcinoma may be influenced by behaviour, and the
immune and hormonal systems.
The present study investigated behavioural and biological
parameters in the female transgenic MT42 TGFx mice. These
female transgenic TGFa mice show an abnormal develop-
ment of the mammary gland, but do not develop spon-
taneous tumours at an increased rate at any site (Jhappan et
al., 1990). This is surprising, since TGFa appears to play a
significant role in mammary tumourigenesis (Bates et al.,
1988; Liu et al., 1987; Sandgren et al., 1990), and female mice
in other transgenic TGFa models exhibit an increased
incidence of mammary tumours (Matsui et al., 1990; Sand-
gren et al., 1990; Stuart, 1984). The expression of TGFoa
mRNA appears equally elevated in both sexes of MT42 mice
(Hilakivi-Clarke et al., 1993a; Jhappan et al., 1990). To in-
vestigate behavioural changes associated with the overexpres-
sion of TGFa in the female mice, we utilised (i) Porsolt's
swim test, which is thought to measure both depressive
behaviour and an animal's ability to cope with stress
(Garcia-Marquez & Armario, 1987; Hilakivi et al., 1989;
Porsolt et al., 1977), (ii) the plusmaze test of anxiety (Lister,
1987), and (iii) the resident-intruder paradigm of aggression
(Miczek, 1987). The NK cell activity, and plasma E2 and
testosterone levels were also measured.
The results indicate that female transgenic TGFa mice
show significantly shorter immobility in the swim test, and
appear less aggressive than their non-transgenic CD-I female
controls. In marked contrast, the male TGFa mice develop
hepatocellular tumours, exhibit a lengthened immobility in
the swim test and are highly aggressive (Hilakivi-Clarke et
al., 1992a). Thus, in addition to the differences in the
tumourigenesis, overexpression of TGFa induces gender-
specific behavioural alterations.
Methods
Animals
Mice of the CD-I background were made transgenic for the
growth factor TGFa (Jhappan et al., 1990) and provided by
Dr Glenn Merlino (NCI, Frederick, MD). An inducible
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TGFa expression vector was constructed by inserting a
917 bp human TGFox cDNA into the pEV142 plasmid, which
contains both the mouse metallothionein 1 (MT1) promoter
and the human growth hormone polyadenylation signal. A
2.3 kb EcoRI MT-TGFx fusion gene fragment was isolated
and microinjected into outbred CD-1 one-cell mouse em-
bryos. In these mice (MT42), the intact MT-TGFa transgene
was stably integrated at a single site containing two copies
per haploid genome, and transmitted in typical Mendelian
fashion. A viable MT42 homogenous transgenic line (42H)
was derived, suggesting that this transgene integrated into a
non-essential genomic site. The distribution of the elevated
expression of TGFa in the MT42 transgenic mice has been
reported elsewhere (Jhappan et al., 1990).
Non-transgenic female CD-1 mice (Charles Rivers, NC)
were used as controls. Upon arrival, these 4-5 week old mice
were housed in groups of 5-10. The animals were main-
tained on a 12 h light- 12 h dark cycle, and allowed ad
libitum access to food and water. When the animals were 123
days old, three female control and three female TGFa mice
were killed by cervical dislocation for a pathological
examination of their liver and pancreas. These organs were
placed in 10% (v/v) formalin, and submitted to Maryland
Medical Laboratory (Baltimore, MD) for histological
analyses.
Apparatus andbehavioural testingprocedures
Swim test The mice were 73 days old when tested in the
swim test. Ten female TGFa and ten controls were used.
Each mouse was placed individually in a plastic cylinder
(height 17 cm, diameter 21 cm) containing 8 cm of water
maintained at about 25°C for 10 min. This 10 min period
included a 2 min acclimatisation period at the beginning of
the test, immediately followed by an 8 min test. The time
spent immobile in the water was scored using a stop-watch
(Hilakivi et al., 1989; Porsolt et al., 1977). A mouse was
judged to be immobile when it was floating almost
motionless.
Porsolt's swim test has been developed to predict the
antidepressant efficacy of different compounds (Porsolt et al.,
1977), but it is also sensitive to the effects of a variety of
stressors (Garcia-Marquez & Armario, 1987; Hilakivi et al.,
1989). Antidepressants shorten, and stressors lengthen the
time spent immobile in the water.
Resident-intruder test Seven 82-day-old female TGFa and 7
control mice, which were previously used in the swim test,
were housed individually for 7 days. Thereafter, these mice
were confronted in their home cage with a group-housed
non-transgenic female intruder which had no previous con-
tact with the resident. Each intruder was used only once. The
body weights ofthe intruders were matched with those of the
residents. During the 8 min test period, an observer
monitored the behaviour of the resident using two stop
watches. The behaviours recorded were the number and
duration of social investigation (sniffing, following, groom-
ing) and aggression (lateral threat, tail rattle, biting, fighting)
(Hilakivi-Clarke et al., 1990; Miczek, 1987).
Plusmaze Behaviour in the plusmaze was measured from
nine female TGFx and nine control mice. These mice were 74
days old, and they were put into an open arena for 3 min
immediately prior to the plusmaze test (Lister, 1987). The
plusmaze was made of transparent Plexiglas and consisted of
two open arms (30 x 5 cm) and two enclosed arms
(30 x 5 cm) with 14.5 cm high side walls. The arms extended
from a central platform, and the floor ofthe closed arms was
painted black. The apparatus was mounted on a Plexiglas
base, raising it 38.5 cm above the floor (Lister, 1987).
The mice were placed in the center of the plusmaze facing
an open arm. During the 3 min test the time spent in each
type of arm were scored using two stop watches. A mouse
was considered to have entered an arm when all four legs
were on the arm. The time spent on the open arms was
expressed as a percentage of the time spent on both the open
and closed arms.
Measurement ofsteroid levels
At the age of 95 days, ten female TGFa and ten control mice
were checked for reproductive cyclicity by examining vaginal
smears taken between 8.00-10.00 a.m. each day for 2 weeks.
The last set ofvaginal smears were collected 30 min prior to
sacrificing the animals. Five mice from each group were then
anesthetised using methoxyflurane inhalant to collect their
blood directly from the heart (n = 5 per group; all these
animals had been previously studied in the swim test). The
blood was placed in tubes, centrifuged, and stored at - 80°C
until it was sent to Diagnostic Assay Services (Gaithersburg, MD). Total plasma 17p-estradiol (E2) and testosterone con-
centrations from the samples were measured using a radioim-
munoassay by Diagnostic Products Corporation (Los Angeles, CA).
Measurement ofimmunologicalfunction
The same animals whose blood was used to measure the
hormonal levels were killed by cervical dislocation, and their
spleens removed immediately post mortem and placed in
Hanks' balanced salt solution containing 10% heat inacti-
vated foetal bovine serum. Single cell suspensions were
prepared, and Natural killer (NK) cell activities were assayed
as described by Arora & Shearer (1982). Target cells were
labelled with 200 iCi of Na2[5`Cr] 04 (Dupont-New England Nuclear, Boston, MA), and washed twice in HBSS contain-
ing 10% FBS and 3 ml Hepes buffer (GIBCO). After count-
ing, target cells were added (100 tlI) to the microtiter wells
containing effector spleen cells, such that different
effector:target cell ratios could be evaluated. The plates were
centrifuged for 3 min at 400 rpm and incubated at 37°C for
4 h in a 95% air:5% CO2 atmosphere. After incubation, the
plates were centrifuged for 3 min at 800 rpm, the supernatant collected with a Titertek Supernatant Collection System (Skatron, Inc., Sterling, VA) and radioactivity measured in a
Beckman Auto Gamma scintillation spectrometer. The
percentage of lysis was determined as described by Arora &
Shearer (1982).
Statistical analysis The statistical tests were performed using the SOLO statistical software (BMDP Statistical Soft-
ware, Los Angeles, CA, USA). Results for the swim test, resident-intruder test, plusmaze, and hormonal assays were
analysed using t-test. Advanced ANOVA was used to analyse the data for NK cell activity. Where appropriate, between-
group comparisons were made using Fisher's Least
Significant Difference test. All probabilities are two-tailed.
Results
Body weight
No difference in body weights were observed between female
TGFa (mean ± s.e.m. body weight at the age of 88 days; 29.2 ± 0.3g) and non-transgenic CD-I mice (30.0 ± 0.3 g).
Histopathology ofpancreas andliver
Pathological examination revealed that the pancreas of the
transgenic TGFa mice contained ductular hyperplasia and
ectasia. Some signs of pancreatitis were also present. All
control pancreas appeared normal. The pathology of the livers in the control and TGFx mice was within normal
limits. One control and all three transgenic mice had minimal
infiltrates oflymphocytes in the parenchyma or portal triands of the liver. In addition, the hepatic tissue of the TGFx mice
contained plasma cells.1028 L.A. HILAKIVI-CLARKE et al.
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Figure 1 The immobility times in the swim test. The duration of
immobility during an 8 min test in the female control and TGFa
mice is reported. The means ± s.e.m. of ten animals per group are
shown. **P<.Ol.
Swim test
The time spent immobile in the water was significantly
shorter in the female TGFa mice than in their CD-1 controls
(t(29) = 2.9, P<.008) (Figure 1).
Resident-intruder test
The female TGFoa mice spent a significantly shorter time
showing aggressive behaviours than the control mice
(t(12) = 2.8, P<.02) (Figure 2). When fighting occurred, it
was always the resident who initiated the attack. The time
spent in active social interactions was also shorter in the
female TGFa mice, when compared with the controls
(t(12) = 3.9, P<.002).
Plusmaze
The behaviour in the plusmaze did not significantly differ
between the female transgenic (mean ± s.e.m. proportion of
time spent on open arms: 28.6 ± 3.6%) and non-transgenic
mice 22.8 ± 4.9%).
Plasma steroid hormone levels
The control mice had a regular 4-5 day estrous cycle. How-
ever, only 20% of the TGFx mice cycled regularly; 40%
appeared to remain in estrous and 40% in anestrus. Plasma
E2 levels were determined from one regularly cycling TGFa
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mice in proestrus, one irregularly cycling TGFa mouse in
proestrus, two irregularly cycling TGFx mice in estrus, and
one irregularly cycling TGFa mouse in metestrus. The stage
of estrous cycle in the control female mice was matched with
that of the TGFa mice. The results showed that the plasma
levels of E2 were significantly elevated by 3-fold in the female
transgenic mice (mean ± s.e.m.; 15.8 ± 1.3 pg ml-' vs con-
trols: 5.0 ± 2.2 pg ml-') (t(1,8) = 4.2 P<.003). In the TGFa
mice, the levels did not appear to be dependent on the stage
of the estrus cycle, whereas in the non-transgenic mice the
levels of E2 were 13-times higher in proestrus than in dies-
trus. The amount of testosterone in the blood was not
significantly different between the female TGFa mice
(4.2 ± 0.8 ng ml-') and their controls (2.7 ± 1.1 ng ml').
Natural killer cell activity
As shown in Figure 3, NK cell activity was significantly
lower by approximately 75% in the female TGFa mice, when
compared with the non-transgenic female control mice
(F(2,24) = 13.8, P<.001).
Discussion
The results of our previous study (Hilakivi-Clarke et al.,
1992a) suggested that the effect of an overexpression of
TGFx on neoplastic transformation in male transgenic mice
may be mediated through a number of factors, including
behaviour, and hormonal and immune systems. The present
study investigated these same parameters in the female TGFa
mice, which do not develop an increased incidence of
tumours at any site (Jhappan et al., 1990). Both the male
(Hilakivi-Clarke et al., 1992a) and female TGFa mice express
a 3-fold elevation in plasma E2 levels and a 3-fold decrease
in NK cell activity. Furthermore, both sexes do not exhibit
alterations in the behaviour in the plusmaze test of anxi-
ety.
The effect of an elevated expression of TGFx on behaviour
in the swim test and resident-intruder paradigm is different in
the male and female transgenic mice. Male transgenic TGFx
mice exhibit an elevated level of aggression and an impaired
ability to cope with stress in the swim test, when compared
with their non-transgenic male CD-1 controls. The data
obtained in the present study indicate that in the swim test
the female TGFx spend less time immobile than the non-
transgenic female control mice, suggesting an improved
ability to cope with stress. Furthermore, aggressive behaviour
is reduced in the female TGFa mouse.
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Figure 2 Aggressive behaviour in the resident-intruder test. The
times spent in aggression during an 8 min test in the female
control and TGFa mice are reported. The means ± s.e.m. of
seven animals per group are shown. *P<.02.
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Figure 3 NK cell activity in the spleen. This activity has been
obtained by using three different effector:target cell ratios in the
female control and TGFx mice. Spleen cells were the effectors
and YAC-l cells were used as targets. The means ± s.e.m. of five
animals per group are shown.
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The present results suggest that the overexpression of
TGFa induces hepatocellular carcinoma in male transgenic
mice, and gender-specific behavioural alterations. Thus, cer-
tain behavioural patterns may be associated with tumouri-
genesis, whereas others may indicate a reduced risk for
developing cancer. However, definitive evidence supporting a
cause and effect relationship between behaviour and tumouri-
genesis remains to be determined. The data obtained in both
human and animal studies suggest that psychosocial factors
may play a role in the development of cancer and influence
survival (Hilakivi-Clarke et al., 1993b). Specifically, these
studies implicate that an impaired ability to cope with stress
increases the- risk to develop cancer and shortens survival
(Hilakivi-Clarke et al., 1993b; Ramirez et al., 1989; Sklar &
Anisman, 1981). In contrast, an improved ability to cope
with stress and improved well-being may reduce cancer risk
(Geyer, 1991) and lengthen survival (Spiegel et al., 1989).
Besides its association with neoplastic transformation, the
physiological roles of TGFax are largely unknown. TGFa can
induce release of luteinising hormone-releasing hormone
(LHRH) in the hypothalamus of female rats (Ojeda et al.,
1990). LHRH stimulates the release of luteinising hormone in
the pituitary, which in turn stimulates estrogen release from
the uterus in females and from the testes in males (Griffin &
Ojeda, 1988). Thus, in the transgenic mice, constitutive
TGFa expression may have increased plasma estrogen levels
via stimulation of the hypothalamus. Alternatively, TGFa
may modulate peripheral conversion of androgens to estro-
gen via increased activity of the aromatase enzyme (Clarke et
al., 1992).
The estrous cycle of the female TGFa animals was abnor-
mal: the females were either almost constantly in estrus or in
anestrus. This may contribute to our difficulties in breeding
the TGFa mice. It is possible that the increased plasma E2
levels resulted from the altered estrus cycle. However, female
rats exposed to clomipramine during the early postnatal
period and subsequently to 7,12-dimethylbenz(a)anthracene,
remain in estrus but their plasma E2 levels are not elevated
(Hilakivi-Clarke et al., 1993c). Thus, alterations in estrus
cycle do not necessarily lead to a change in plasma E2
levels.
The less depressive-like tendencies apparent in the female
TGFa mice suggest that high levels of estrogen may protect
from depression, and low levels may induce this behaviour.
Ovariectomy increases depressive-like behaviour in female
mice (Bernardi et al., 1989). Estradiol does not affect
behaviour in the swim test in intact females, but it reverses
the effects of ovariectomy (Bernardi et al., 1989). Estrogen
also influences aggressive behaviour. Experiments conducted
by van de Poll et al. (1985) have shown that chronic treat-
ment with estrogen induced high levels of aggression in male
but not female rats. These findings are in accordance with the
present and earlier data (Hilakivi-Clarke et al., 1992),
indicating that female TGFz mice exhibit less and male
TGFa more aggressive behaviour than their non-transgenic
CD-I controls.
There are at least three explanations for the present
findings. (i) There may be a factor protecting of the females
from developing tumours. For example, the female TGFax
mice may be 'resistant' to the effects of elevated E2 levels
because of their sex, the male TGFa mice being less able to
cope with alternating E2 levels. (ii) The interaction between
TGFa and estrogen may be critical for liver tumours in male
mice, but not in female mice. (iii) It is possible that reduced
NK cell activity or increased plasma levels of E2 do not
directly participate in neoplastic processes. However, a
number of studies strongly support the connection between
these biological variables and cancer (d'Arville & Johnson,
1990; Chuang et al., 1990; Yager & Shi, 1991). Our previous
and present results suggest that the elevation in the plasma
levels of E2 and reduction in NK cell activity occur
independently of the tumourigenic effects of TGFa.
In conclusion, our findings indicate that the female trans-
genic TGFax mice which do not develop an increased
incidence of tumours at any site, are well able to cope with
stressful situations and are not aggressive. In contrast, the
male TGFa mice which develop hepatocellular carcinoma,
exhibit behaviours characteristic of both an impaired ability
to cope with stress and increased aggressivity several months
prior to the appearance of these tumours (Hilakivi-Clarke et
al., 1992). Thus, the data suggest that TGFa promotes
tumour growth only in male transgenic mice, and causes
gender-specific behavioural alterations. The mechanisms
through which these sex-related differences in behaviour and
tumourigenesis are mediated, remain unclear. Our future
experiments will determine whether the development of
hepatocarcinoma in male TGFa animals is associated with an
impaired ability to cope with stress and elevated aggressive
tendencies, and/or whether manipulations leading to
impaired ability to cope with stress promote tumourigenesis
in female TGFa mice.
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